desvenlafaxine

Generic: desvenlafaxine

Labeler: slate run pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name desvenlafaxine
Generic Name desvenlafaxine
Labeler slate run pharmaceuticals, llc
Dosage Form TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

desvenlafaxine succinate 25 mg/1

Manufacturer
Slate Run Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 70436-036
Product ID 70436-036_44e079c1-e1e0-a87d-e063-6294a90a78f8
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA210014
Listing Expiration 2026-12-31
Marketing Start 2021-01-05

Pharmacologic Class

Classes
cytochrome p450 2d6 inhibitors [moa] norepinephrine uptake inhibitors [moa] serotonin uptake inhibitors [moa] serotonin and norepinephrine reuptake inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 70436036
Hyphenated Format 70436-036

Supplemental Identifiers

RxCUI
1607617 1874553 1874559
UPC
0370436036042 0370436012060 0370436012046
UNII
ZB22ENF0XR

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name desvenlafaxine (source: ndc)
Generic Name desvenlafaxine (source: ndc)
Application Number ANDA210014 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 25 mg/1
source: ndc
Packaging
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70436-036-04)
source: ndc

Packages (1)

Ingredients (1)

desvenlafaxine succinate (25 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "44e079c1-e1e0-a87d-e063-6294a90a78f8", "openfda": {"upc": ["0370436036042", "0370436012060", "0370436012046"], "unii": ["ZB22ENF0XR"], "rxcui": ["1607617", "1874553", "1874559"], "spl_set_id": ["44f4b928-d5b8-44e7-bfa6-81fb0dc1a718"], "manufacturer_name": ["Slate Run Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70436-036-04)", "package_ndc": "70436-036-04", "marketing_start_date": "20210105"}], "brand_name": "Desvenlafaxine", "product_id": "70436-036_44e079c1-e1e0-a87d-e063-6294a90a78f8", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2D6 Inhibitors [MoA]", "Norepinephrine Uptake Inhibitors [MoA]", "Serotonin Uptake Inhibitors [MoA]", "Serotonin and Norepinephrine Reuptake Inhibitor [EPC]"], "product_ndc": "70436-036", "generic_name": "Desvenlafaxine", "labeler_name": "Slate Run Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Desvenlafaxine", "active_ingredients": [{"name": "DESVENLAFAXINE SUCCINATE", "strength": "25 mg/1"}], "application_number": "ANDA210014", "marketing_category": "ANDA", "marketing_start_date": "20210105", "listing_expiration_date": "20261231"}